Compound comparison

NAD+ vs MOTS-c

NAD+ and MOTS-c are both discussed in longevity and metabolism research, one as a coenzyme and one as a mitochondrial-encoded peptide.

Updated September 2026
This page is an educational comparison, not medical advice, and it does not recommend either compound. Regulatory status differs between them; see the table below.

NAD+ and MOTS-c are often compared because both are tied to cellular energy and aging. NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme, not a peptide, that the body makes from dietary precursors. MOTS-c is a peptide encoded in mitochondrial DNA, studied as a metabolic regulator. Neither is an FDA-approved treatment.

At a glance

NAD+MOTS-c
What it isEssential coenzyme (not a peptide) involved in cellular energy production and DNA repair, made by the body from dietary precursorsPeptide encoded in mitochondrial DNA, studied as a metabolic regulator and sometimes called an exercise mimetic
How it's thought to workCofactor for sirtuins (SIRT1 to SIRT7), proteins involved in DNA repair and energy metabolism; levels are described as declining with ageStudied for moving to the cell nucleus under metabolic stress and activating AMPK signaling, affecting glucose and fat metabolism
Regulatory statusInjectable NAD+ is not an FDA-approved treatmentNot FDA-approved for any human use
Strength of evidenceAging research is mostly in animals and labs; a small 2019 human pilot study measured how infused NAD+ is processedInsulin-sensitivity and exercise findings come from animal studies; human research is at an early stage
Reported side effectsFlushing (warmth and discomfort) that typically passes within 15 to 30 minutes; nauseaInjection site reactions; long-term human data is limited
Common vial sizes100mg, 500mg, 1000mg5mg, 10mg
Mixing math example500 mg + 5 mL BAC water = 100,000 mcg/mL, 1 mg per unit10 mg + 2 mL BAC water = 5,000 mcg/mL, 50 mcg per unit

Key differences

NAD+ acts as a cofactor for sirtuins (SIRT1 to SIRT7), proteins involved in DNA repair, mitochondrial function and energy metabolism. MOTS-c is studied for moving to the cell nucleus under metabolic stress and activating AMPK signaling, affecting glucose use and fat metabolism.

Both are described as declining with age: NAD+ levels are described as falling with age, and declining MOTS-c levels have been observed to correlate with aging.

NAD+ has a distinctive reported side effect, flushing that can feel intense and typically passes within 15 to 30 minutes, along with nausea. MOTS-c's reported side effects are injection site reactions.

What the research covers

Most NAD+ aging research is in laboratory and animal models; human research on directly administered NAD+ is small, including a 2019 pilot study of how infused NAD+ is processed. MOTS-c's findings on insulin sensitivity and exercise capacity come from animal studies, and human research is at an early stage.

Sources

  1. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Grant R et al. Frontiers in Aging Neuroscience, 2019. Human trial
  2. NAD+ in aging, metabolism, and neurodegeneration. Verdin E et al. Science, 2015. Review
  3. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Lee C et al. Cell Metabolism, 2015. Preclinical
  4. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Reynolds JC et al. Nature Communications, 2021. Human trial

How we choose and check sources

Frequently asked questions

What is the difference between NAD+ and MOTS-c?

NAD+ is a coenzyme that acts as a cofactor for sirtuins. MOTS-c is a mitochondrial-encoded peptide studied for activating AMPK signaling.

Is NAD+ a peptide?

No. NAD+ is a coenzyme, not a peptide, though it is commonly discussed alongside peptides. MOTS-c is a peptide.

Is NAD+ or MOTS-c FDA-approved?

Injectable NAD+ is not an FDA-approved treatment, and MOTS-c is not FDA-approved for any human use.

Is there human research on NAD+ or MOTS-c?

Human research is early for both. NAD+ has a small 2019 pilot study of infused NAD+, and MOTS-c findings come mainly from animal studies.

Both entries, plus the calculator

The PeptidesAI app covers NAD+, MOTS-c and 68 other compounds, with a reconstitution calculator, a dose log and reminders. Free to download on iPhone.

Download on the App Store

Related